Platelet Aggregation After Thrombolytic Therapy
Explore this paper's citation graph
Summary
An unexpected side effect of thrombolytic treatment with urokinase is discovered, the enhancement of platelet aggregation, and it seems wise to prevent this side effect by using antiaggregant drugs for this purpose.
- Type
- article
- Published
- 1980-02-01
- Cited by
- 19
- References
- 13
- OpenAlex
- https://openalex.org/W1977940639
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:46412579
Keywords
Medicine, Platelet aggregation, Platelet, Cardiology, Internal medicine
References
- Platelet aggregation induced by soluble fibrin monomer complexes.
- Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
- The aggregation of blood platelets
- L'augmentation de l'agrégation plaquettaire. Effet inattendu de la thérapeutique fibrinolytique.
- [Platelet hyperaggregability secondary to thrombolytic treatment].
Cited by
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
- Tissue-type plasminogen activator inhibits aggregation of platelets in vitro.
- Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirin.
- Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis.
- No electrical instability after intracoronary streptokinase administered into sinus node or AV node of dogs.
- Possible mechanism of vascular reocclusion after initially successful thrombolysis with recombinant tissue-type plasminogen activator.
- "In vitro" activity of urokinase on platelet function and on ADP degradation by vascular tissue.
- Platelet function during thrombolytic therapy with anistreplase
- Activation of the hemostatic system during thrombolytic therapy.
- Attenuation of the inhibitory effect of prostacyclin on platelet function after tissue plasminogen activator or streptokinase infusion in the rabbit
- Effect of recombinant tissue-type plasminogen activator on ten platelet membrane glycoproteins
- Influence of thrombolytic agents on human platelet function.
- Platelet and neutrophil imaging techniques in the investigation of the response to thrombolytic therapy and the no-reflow phenomenon.
- Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.
- Differential effects of low‐dose tissue plasminogen activator and streptokinase on platelet aggregation
- The effect of plasmin on platelet function.
- Eicosanoids in the Cardiovascular and Renal Systems
- Markedplatelet activation invivoafter intravenous streptokinase inpatients withacutemyocardial infarction
- Eicosanoids in myocardial ischaemia and injury
Related papers
- ФОРМИРОВAНИЕ ГОТОВНОСТИ БУДУЩИХ ПЕДAГОГОВ К ОРГAНИЗAЦИИ РAБОТЫ ПО РAЗВИТИЮ ВAЛЕОЛОГИЧЕСКОЙ КУЛЬТУРЫ ШКОЛЬНИКОВ
- चितलवाना पंचायत समिति में मानव गरीबी सूचकांक - 2016 ( à¤à¤• गà¥à¤°à¤¾à¤® सà¥à¤¤à¤°à¥€à¤¯ à¤à¥Œà¤—ोलिक अधà¥à¤¯à¤¯à¤¨ )
- A GEOMETRIC MEAN IN THE FURUTA INEQUALITY
- The Novel Effect of a New Prostacyclin Analogue ZK36374 on the Aggregation of Human Platelets in Whole Blood